Startups

Senior Director, Clinical Science, Early-Stage Clinical Development

Revolution Medicines · Redwood City, California, United States · On-site

← All jobs
About Revolution Medicines

Backed by GV.

About the role

We are seeking an experienced clinical science drug developer to serve as Senior Director, Clinical Science, in support of Revolution Medicines’ molecule(s) in clinical or late pre-clinical development. In this critical role, you will support various clinical science deliverables and enable effective and efficient execution of the clinical development plan for a molecule(s) within its particular indication(s). Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • Bachelor’s Degree (life sciences preferred) plus Advanced Clinical/Science Degree is required (e.g., PharmD, PhD, MSN, MPH, etc)
  • Minimum 7+ years experience in clinical development in the pharmaceutical/biotech industry and/or academic/other clinical trial setting, some experience in and understanding of early phase drug development preferred
  • Extensive experience working with the principles and techniques of data analysis, interpretation, and clinical relevance as related to the pharmaceutical/biotech industry
  • Experience in independent generation of trial design, protocol writing/ICF (writing or amendment), constructing appropriate CRF and coordinating cross-functionally
  • In-depth therapeutic area experience/expertise, and relevant clinical trial experience (or clear ability to adapt with transferable skills)
  • Proven ability to work effectively and efficiently within cross-functional teams involved in the drug development process, proven ability to efficiently integrate multiple perspectives into the CDP
More about this role

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

We are seeking an experienced clinical science drug developer to serve as Senior Director, Clinical Science, in support of Revolution Medicines’ molecule(s) in clinical or late pre-clinical development. In this critical role, you will support various clinical science deliverables and enable effective and efficient execution of the clinical development plan for a molecule(s) within its...

Read the full posting on Revolution Medicines's site ↗

Clinical Development

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.